Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL2000037	DS-8201a	trastuzumab deruxtecan	Lyophilized	Biological Products	Import Drug Application	2020-04-15	Daiichi Sankyo, Inc.	Daiichi Sankyo Co Ltd	In Review	2020-04-14	view
JXSL2000147	DS-8201a	trastuzumab deruxtecan	Lyophilized	Biological Products(2.2)	Import Drug Application	2020-09-01	Daiichi Sankyo, Inc.	Daiichi Sankyo Co Ltd	In Review	2020-08-31	view
JXSL2000178	DS-8201a	trastuzumab deruxtecan	Lyophilized	Biological Products(2.2)	Import Drug Application	2020-10-14	Daiichi Sankyo, Inc.	Daiichi Sankyo Co Ltd	In Review	2020-10-12	view
JXSL2000237	DS-8201a	trastuzumab deruxtecan	Lyophilized	Biological Products(2.2)	Import Drug Application	2021-01-01	Daiichi Sankyo, Inc.	Daiichi Sankyo Co Ltd	In Review	2021-01-01	view
JXSL2100002	DS-8201a	trastuzumab deruxtecan	Lyophilized	Biological Products(2.2)	Import Drug Application	2021-01-07	Daiichi Sankyo, Inc.	Daiichi Sankyo Co Ltd	In Review	2021-01-06	view
JXSL2100011	DS-8201a	trastuzumab deruxtecan	Lyophilized	Biological Products(2.2)	Import Drug Application	2021-01-25	Daiichi Sankyo, Inc.	Daiichi Sankyo Co Ltd	In Review	2021-01-25	view
JXHB2100034	AC220片	quizartinib hydrochloride	Tablet	Chemical Drugs(1)	Supplementary Application	2021-04-03	Daiichi Sankyo, Inc.	Daiichi Sankyo Co Ltd	In Review	2021-04-02	view
JXHB2100035	AC220片	quizartinib hydrochloride	Tablet	Chemical Drugs(1)	Supplementary Application	2021-04-03	Daiichi Sankyo, Inc.	Daiichi Sankyo Co Ltd	In Review	2021-04-02	view